[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100568657":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":24,"locations":18,"responsibleParty":30,"collaborators":18,"id":34,"slug":18,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":35,"sex":41,"minAge":18,"maxAge":18,"enrollmentInfo":42,"targetDuration":18,"studyType":45,"phases":46,"briefSummary":48,"conditions":49,"keywords":51,"overallStatus":57,"whyStopped":18,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":63,"leadSponsor":65,"locationsCount":18},{"fullName":5,"class":6},"The Third Affiliated Hospital of Guangzhou Medical University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Care bundle group","EXPERIMENTAL","1\\. Risk evaluation for PPH and Reserve plan; 2.Assess blood loss using Estimated Blood Loss Form and amnion fluid collection drape; 3. Satisfy any of the following conditions: i. If the estimated blood loss reaches 500ml but is less than 1000ml, and any of the following abnormal indicators are present; ii. If the estimated blood loss reaches 1000ml, no other indicators need to be considered:\n\n1. Lack of uterine contractions\n2. Persistent bleeding\n3. Shock index (heart rate\u002Fsystolic blood pressure) was greater than 0.9 Initiate the following protocols①, ②, ③, ④\n\n   * Maintain uterus tone (Administration of Oxytocin and second-line medications to promote uterine contraction)\n\n     * Intravenous infusion ③ Administered tranexamic acid\n\n       * Multi-methods and Multi-disciplinary",[13],"Other: A care bundle",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual care group","NO_INTERVENTION","The usual care group does not receive a PPH risk assessment and estimates blood loss visually and used various interventions for postpartum hemorrhage in accordance with local or national guidelines.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"A care bundle","1. Risk evaluation for PPH and Reserve plan;\n2. Assess blood loss using Estimated Blood Loss Form and amnion fluid collection drape;\n3. Satisfy any of the following conditions: i. If the estimated blood loss reaches 500ml but is less than 1000ml, and any of the following abnormal indicators are present; ii. If the estimated blood loss reaches 1000ml, no other indicators need to be considered: 1） Lack of uterine contractions 2） Persistent bleeding 3）Shock index (heart rate\u002Fsystolic blood pressure) was greater than 0.9 Initiate the following protocols①, ②, ③, ④\n\n   * Maintain uterus tone (Administration of Oxytocin and second-line medications to promote uterine contraction)\n\n     * Intravenous infusion ③ Administered tranexamic acid ④ Multi-methods and Multi-disciplinary",[9],[25],{"name":26,"role":27,"phone":28,"phoneExt":18,"email":29},"Lizi M.D.","CONTACT","086-13265352553","2022390064@gzhmu.edu.cn",{"type":31,"investigatorFullName":32,"investigatorTitle":33,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"SPONSOR_INVESTIGATOR","Dunjin Chen","Principal Investigator","100568657",false,"NCT06684080","The Effectiveness of a Care Bundle to Prevent Postpartum Hemorrhage After Cesarean Delivery","A Cluster Randomized Trial on the Effectiveness of a Care Bundle to Prevent Postpartum Hemorrhage After Cesarean Delivery (Re-Team)","RE-TEAM","Inclusion Criteria:\n\n* Hospital level\n\n  1. Public hospitals\n  2. There are more than 100 cesarean deliveries per year\n* Patient level\n\n  1. Cesarean delivery\n  2. Sign informed consent\n\nExclusion Criteria:\n\n* Hospital level\n\n  1\\. Data verification information cannot be provided\n* Pregnant woman level 1. No blood routine results within 2 weeks before surgery","FEMALE",{"count":43,"type":44},52000,"ESTIMATED","INTERVENTIONAL",[47],"NA","Delays in the detection or inconsistent use of effective interventions of postpartum hemorrhage can result in complications or death. We designed a cluster-randomized trial to assess a multi-component strategy for the detection and treatment of postpartum hemorrhage after cesarean delivery.",[50],"Cesarean Delivery",[52,53,54,55,56],"Postpartum Hemorrhage","cesarean delivery","Randomized trial","Detection","treatment","NOT_YET_RECRUITING","2024-12-31",{"date":60,"type":61},"2025-01-01","ACTUAL",{"date":60,"type":44},{"date":64,"type":44},"2027-06-30",{"name":32,"class":6}]